Pilocarpine after cataract and Kahook goniotomy
Official title: A Prospective Randomized Control Trial of Pilocarpine Use After Combined Cataract/Kahook Dual Blade Surgery
Run by Montefiore Medical Center · NCT03933631 · Data updated 2026-11-12
This trial will test whether giving pilocarpine after combined cataract and Kahook Dual Blade surgery helps lower eye pressure and reduce the need for glaucoma medicines in people with open-angle glaucoma or ocular hypertension.
Quick facts
| Phase | Phase 3 |
|---|---|
| Study type | Interventional |
| Ages | 30 Years to 100 Years |
| Sex | All |
| Enrollment | 142 (estimated) |
| Sponsor | Montefiore Medical Center Academic / other |
| Locations | 2 sites (The Bronx, New York and 1 other locations) |
| Status | Recruiting |
| Started | May 1, 2019 |
| Main results expected | June 2028 |
| Study ends | December 2028 |
| Registry record updated | November 10, 2025 |
| Trial ID | NCT03933631 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with ocular hypertension or open-angle glaucoma who are scheduled for combined cataract surgery with Kahook Dual Blade goniotomy at Montefiore and have no prior eye surgeries are ideal candidates.
✕Probably not a fit
Patients with prior intraocular surgeries, other types of glaucoma not appropriate for KDB, or those who cannot tolerate pilocarpine side effects are unlikely to benefit from this approach.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This single-center Phase 3 interventional study enrolls patients having combined cataract surgery with Kahook Dual Blade goniotomy to see if adding postoperative pilocarpine improves surgical success. Participants receive standard postoperative care including topical steroid and antibiotic with pilocarpine added for the intervention group, and outcomes such as intraocular pressure and medication burden are tracked over follow-up. The Kahook procedure removes strips of trabecular meshwork to improve aqueous outflow, while pilocarpine acts by tightening the ciliary muscle and opening trabecular spaces. The trial is conducted at Montefiore with a single provider to standardize surgical technique and postoperative management.
Why it matters
Potential benefit: If successful, adding pilocarpine could further lower intraocular pressure after cataract+KDB surgery and reduce reliance on glaucoma medications.
How similar studies have gone: Pilocarpine is a well-known glaucoma drug but its routine postoperative use after KDB goniotomy is not well studied, and previous work on adjunctive medical therapies for MIGS has shown mixed results.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with ocular hypertension or open angle glaucoma undergoing combined cataract surgery with KDB in a single surgical center at Montefiore Medical Center with a single provider Exclusion Criteria: * Patients with previous history of eye surgeries (including laser procedures)
Where it's running
-
Montefiore Wakefield Campus
The Bronx, New York, United States Recruiting -
Montefiore Medical Center
The Bronx, New York, United States Recruiting
Study contacts
- Principal investigator: Wen-Jeng (Melissa) Yao, MD — Montefiore Medical Center
- Study coordinator: Wen-Jeng (Melissa) Yao, MD
- Email: WYAO@montefiore.org
- Phone: 718-920-2020
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Balance training for people with glaucoma
A randomized study tests whether a structured eight-week balance program helps adults with glaucoma improve balance, reduce fall risk, and lessen fear of falling.
-
Eye drops Rhopressa vs Timolol to protect nerve cells in glaucoma
In adults with open-angle glaucoma, this study tests whether Rhopressa helps preserve retinal nerve cells better than Timolol while both lower eye pressure.
-
Comparison of FT-1000 non-contact tonometry with Goldmann applanation tonometry in glaucoma patients
This study tests whether the FT-1000 non-contact tonometer gives measurements that agree with the Goldmann applanation tonometer in adults with glaucoma.
-
Removing the ripcord from a glaucoma drainage device after 3 months
This study tests whether removing the ripcord from an implanted glaucoma drainage device changes eye pressure for adults with open-angle glaucoma.
-
Glaucoma and Brain Changes: How Brain Structure and Size See What Glaucoma Is Doing
This study tests whether glaucoma is linked to broader brain changes by comparing brain MRI and eye health over time in people with glaucoma and matched controls.
-
Long-Term Results After Ab-interno Trabeculotomy for Glaucoma
This study tests whether ab-interno trabeculotomy with the Trabectome can provide sustained intraocular pressure reduction in glaucoma patients who had the procedure between 2019 and 2021.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.